Endocyte (ECYT) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Join SI Premium – FREE
Endocyte (NASDAQ: ECYT) reported Q2 EPS of ($0.33), $0.07 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Endocyte (ECYT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Bogota Financial Corp. (BSBK) Reports Q2 EPS of $0.06
- ExxonMobil Q2 profit falls short of forecasts, shares slide
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
